Cargando…

Structural-Guided Identification of Small Molecule Inhibitor of UHRF1 Methyltransferase Activity

Ubiquitin-like containing plant homeodomain Ring Finger 1 (UHRF1) protein is recognized as a cell-cycle-regulated multidomain protein. UHRF1 importantly manifests the maintenance of DNA methylation mediated by the interaction between its SRA (SET and RING associated) domain and DNA methyltransferase...

Descripción completa

Detalles Bibliográficos
Autores principales: Awal, Md Abdul, Nur, Suza Mohammad, Al Khalaf, Ali Khalaf, Rehan, Mohd, Ahmad, Aamir, Hosawi, Salman Bakr I., Choudhry, Hani, Khan, Mohammad Imran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382028/
https://www.ncbi.nlm.nih.gov/pubmed/35991572
http://dx.doi.org/10.3389/fgene.2022.928884
_version_ 1784769210113589248
author Awal, Md Abdul
Nur, Suza Mohammad
Al Khalaf, Ali Khalaf
Rehan, Mohd
Ahmad, Aamir
Hosawi, Salman Bakr I.
Choudhry, Hani
Khan, Mohammad Imran
author_facet Awal, Md Abdul
Nur, Suza Mohammad
Al Khalaf, Ali Khalaf
Rehan, Mohd
Ahmad, Aamir
Hosawi, Salman Bakr I.
Choudhry, Hani
Khan, Mohammad Imran
author_sort Awal, Md Abdul
collection PubMed
description Ubiquitin-like containing plant homeodomain Ring Finger 1 (UHRF1) protein is recognized as a cell-cycle-regulated multidomain protein. UHRF1 importantly manifests the maintenance of DNA methylation mediated by the interaction between its SRA (SET and RING associated) domain and DNA methyltransferase-1 (DNMT1)-like epigenetic modulators. However, overexpression of UHRF1 epigenetically responds to the aberrant global methylation and promotes tumorigenesis. To date, no potential molecular inhibitor has been studied against the SRA domain. Therefore, this study focused on identifying the active natural drug-like candidates against the SRA domain. A comprehensive set of in silico approaches including molecular docking, molecular dynamics (MD) simulation, and toxicity analysis was performed to identify potential candidates. A dataset of 709 natural compounds was screened through molecular docking where chicoric acid and nystose have been found showing higher binding affinities to the SRA domain. The MD simulations also showed the protein ligand interaction stability of and in silico toxicity analysis has also showed chicoric acid as a safe and nontoxic drug. In addition, chicoric acid possessed a longer interaction time and higher LD50 of 5000 mg/kg. Moreover, the global methylation level (%5 mC) has been assessed after chicoric acid treatment was in the colorectal cancer cell line (HCT116) at different doses. The result showed that 7.5 µM chicoric acid treatment reduced methylation levels significantly. Thus, the study found chicoric acid can become a possible epidrug-like inhibitor against the SRA domain of UHRF1 protein.
format Online
Article
Text
id pubmed-9382028
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93820282022-08-18 Structural-Guided Identification of Small Molecule Inhibitor of UHRF1 Methyltransferase Activity Awal, Md Abdul Nur, Suza Mohammad Al Khalaf, Ali Khalaf Rehan, Mohd Ahmad, Aamir Hosawi, Salman Bakr I. Choudhry, Hani Khan, Mohammad Imran Front Genet Genetics Ubiquitin-like containing plant homeodomain Ring Finger 1 (UHRF1) protein is recognized as a cell-cycle-regulated multidomain protein. UHRF1 importantly manifests the maintenance of DNA methylation mediated by the interaction between its SRA (SET and RING associated) domain and DNA methyltransferase-1 (DNMT1)-like epigenetic modulators. However, overexpression of UHRF1 epigenetically responds to the aberrant global methylation and promotes tumorigenesis. To date, no potential molecular inhibitor has been studied against the SRA domain. Therefore, this study focused on identifying the active natural drug-like candidates against the SRA domain. A comprehensive set of in silico approaches including molecular docking, molecular dynamics (MD) simulation, and toxicity analysis was performed to identify potential candidates. A dataset of 709 natural compounds was screened through molecular docking where chicoric acid and nystose have been found showing higher binding affinities to the SRA domain. The MD simulations also showed the protein ligand interaction stability of and in silico toxicity analysis has also showed chicoric acid as a safe and nontoxic drug. In addition, chicoric acid possessed a longer interaction time and higher LD50 of 5000 mg/kg. Moreover, the global methylation level (%5 mC) has been assessed after chicoric acid treatment was in the colorectal cancer cell line (HCT116) at different doses. The result showed that 7.5 µM chicoric acid treatment reduced methylation levels significantly. Thus, the study found chicoric acid can become a possible epidrug-like inhibitor against the SRA domain of UHRF1 protein. Frontiers Media S.A. 2022-08-03 /pmc/articles/PMC9382028/ /pubmed/35991572 http://dx.doi.org/10.3389/fgene.2022.928884 Text en Copyright © 2022 Awal, Nur, Al Khalaf, Rehan, Ahmad, Hosawi, Choudhry and Khan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Awal, Md Abdul
Nur, Suza Mohammad
Al Khalaf, Ali Khalaf
Rehan, Mohd
Ahmad, Aamir
Hosawi, Salman Bakr I.
Choudhry, Hani
Khan, Mohammad Imran
Structural-Guided Identification of Small Molecule Inhibitor of UHRF1 Methyltransferase Activity
title Structural-Guided Identification of Small Molecule Inhibitor of UHRF1 Methyltransferase Activity
title_full Structural-Guided Identification of Small Molecule Inhibitor of UHRF1 Methyltransferase Activity
title_fullStr Structural-Guided Identification of Small Molecule Inhibitor of UHRF1 Methyltransferase Activity
title_full_unstemmed Structural-Guided Identification of Small Molecule Inhibitor of UHRF1 Methyltransferase Activity
title_short Structural-Guided Identification of Small Molecule Inhibitor of UHRF1 Methyltransferase Activity
title_sort structural-guided identification of small molecule inhibitor of uhrf1 methyltransferase activity
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382028/
https://www.ncbi.nlm.nih.gov/pubmed/35991572
http://dx.doi.org/10.3389/fgene.2022.928884
work_keys_str_mv AT awalmdabdul structuralguidedidentificationofsmallmoleculeinhibitorofuhrf1methyltransferaseactivity
AT nursuzamohammad structuralguidedidentificationofsmallmoleculeinhibitorofuhrf1methyltransferaseactivity
AT alkhalafalikhalaf structuralguidedidentificationofsmallmoleculeinhibitorofuhrf1methyltransferaseactivity
AT rehanmohd structuralguidedidentificationofsmallmoleculeinhibitorofuhrf1methyltransferaseactivity
AT ahmadaamir structuralguidedidentificationofsmallmoleculeinhibitorofuhrf1methyltransferaseactivity
AT hosawisalmanbakri structuralguidedidentificationofsmallmoleculeinhibitorofuhrf1methyltransferaseactivity
AT choudhryhani structuralguidedidentificationofsmallmoleculeinhibitorofuhrf1methyltransferaseactivity
AT khanmohammadimran structuralguidedidentificationofsmallmoleculeinhibitorofuhrf1methyltransferaseactivity